President Trump said Friday the U.S. would halt its funding of the World Health Organization and pull out of the agency, accusing it of protecting China as the coronavirus pandemic took off. Learn more here. Article by Andrew Joseph and Helen Braswell
The article looks at Trump's rationale for holding funding for WHO, the international body leading the global health response to the CoVid-19 pandemic. Learn more here. Article by Helen Branswell
Professor Arthur Caplan is Director of Medical Ethics at New York University and says there is no guarantee a vaccine for COVID-19 will even be found, let alone able to be distributed to the world's population. Learn more here. Article by Sammi Taylor
Take a look at Dr. Caplan's perspective on a challenge study to create a vaccine fast during a pandemic. Learn more here. Article by Art Caplan
More than one million people around the world have been deemed recovered from the coronavirus, but beating the initial sickness may be just the first of many battles for those who have survived. Learn more here. Article by Lisa Du
Over the next few decades, economists, epidemiologists, public health experts, historians, philosophers, sociologists, physicians, psychologists, and others will work to untangle the interwoven threads. Even now it takes a village just to answer what seems to be a simple question: How many people have died from Covid-19? Learn more here. Article by Vinay Prasad and [...]
Would it be fair if a protestor used a ventilator after contracting COVID-19 from the protests when resources are limited? Learn more here. Article by Dominic Sisti, Moti Gorin, Emily Largent and Arthur Caplan
Hospitals and physicians around the country are sharply criticizing the federal government for the uneven and opaque way it is distributing its supply of the Covid-19 drug remdesivir. Learn more here. Article by Eric Boodman and Casey Ross
Progress on a coronavirus vaccine is moving at record speed, with some experts predicting widespread availability by spring 2021. But without a solid plan for distribution, bioethicist Arthur Caplan told Business Insider "there will be fights about who gets priority." Learn more here. Article by Sarah Kramer
Governments, companies and academic labs are accelerating their efforts amid geopolitical crosscurrents, questions about safety and the challenges of producing enough doses for billions of people. Learn more here. Article by David Sanger
